102 related articles for article (PubMed ID: 9345599)
1. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
Lafarge-Frayssinet C; Duc HT; Frayssinet C; Sarasin A; Anthony D; Guo Y; Trojan J
Cancer Gene Ther; 1997; 4(5):276-85. PubMed ID: 9345599
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
[TBL] [Abstract][Full Text] [Related]
3. IGF-I triple helix gene therapy of rat and human gliomas.
Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated anti insulin-like growth factor I gene transfer for the treatment of hepatocellular carcinoma.
Lafarge-Frayssinet C; Martin C; Van Binh PN; Achard-Ellouk S; Duc HT; Frayssinet C; Cardoso G; Desauty G; Warnet JM; Bréchot C; Sarasin A
Anticancer Res; 2002; 22(6C):3895-904. PubMed ID: 12553010
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy of tumors expressing IGF-I].
Trojan J; Duc HT; Lafarge-Frayssinet C; Upegui-Gonzales LC; Swiercz B; Bismuth H; Hor F; Anthony D; Guo Y; Ilan J
C R Seances Soc Biol Fil; 1996; 190(1):165-9. PubMed ID: 8881277
[TBL] [Abstract][Full Text] [Related]
6. IGF-I triple helix strategy in hepatoma treatment.
Upegui-Gonzalez LC; Ly A; Sierzega M; Jarocki P; Trojan L; Duc HT; Pan Y; Shevelev A; Henin D; Anthony D; Nowak W; Popiela T; Trojan J
Hepatogastroenterology; 2001; 48(39):660-6. PubMed ID: 11462897
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
[TBL] [Abstract][Full Text] [Related]
8. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice.
Liu X; Turbyville T; Fritz A; Whitesell L
Cancer Res; 1998 Dec; 58(23):5432-8. PubMed ID: 9850076
[TBL] [Abstract][Full Text] [Related]
10. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
[TBL] [Abstract][Full Text] [Related]
11. Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model.
Shevelev A; Burfeind P; Schulze E; Rininsland F; Johnson TR; Trojan J; Chernicky CL; Hélène C; Ilan J; Ilan J
Cancer Gene Ther; 1997; 4(2):105-12. PubMed ID: 9080119
[TBL] [Abstract][Full Text] [Related]
12. Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cells.
Trabado S; Nguyen Van Binh P; Martin C; Lafarge-Frayssinet C; Thevenin M; Baudouin F; Warnet JM; Duc HT
Biomed Pharmacother; 2006 Dec; 60(10):693-7. PubMed ID: 17071049
[TBL] [Abstract][Full Text] [Related]
13. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.
Long L; Rubin R; Baserga R; Brodt P
Cancer Res; 1995 Mar; 55(5):1006-9. PubMed ID: 7866982
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression.
Sargent L; Dragan YP; Babcock K; Wiley J; Klaunig J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2992-7. PubMed ID: 8674053
[TBL] [Abstract][Full Text] [Related]
16. [Effects of antisense 6 gene on colon cancer cells].
Zhang ZY; Xu KS; Yang GY; Wang JS; Gao Y; Liu YF; Shuai J; Wang JY; Li SY; Shou NH; Niu J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2645-8. PubMed ID: 18162155
[TBL] [Abstract][Full Text] [Related]
17. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
19. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
Uto H; Ido A; Moriuchi A; Onaga Y; Nagata K; Onaga M; Tahara Y; Hori T; Hirono S; Hayashi K; Tsubouchi H
Cancer Res; 2001 Jun; 61(12):4779-83. PubMed ID: 11406552
[TBL] [Abstract][Full Text] [Related]
20. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
